BioCryst Pharmaceuticals Inc (NAS:BCRX)
$ 7.82 -0.37 (-4.52%) Market Cap: 1.62 Bil Enterprise Value: 2.18 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 75/100

BioCryst Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 04:30PM GMT
Release Date Price: $12.49 (+2.88%)
Tazeen Ahmad
BofA Securities, Research Division - VP

Good afternoon, everyone. Thanks for joining us back here at the Bank of America Healthcare Conference virtually again this year. It's my pleasure to have our next presenting company with us, BioCryst. BioCryst actually has a special place in my heart. I've been covering you guys ever since I joined the firm over a decade ago. So we have a long history. And it's great to see that you guys have gotten the success that you deserve.

So with that, I'll introduce CEO, Jon Stonehouse. Jon, welcome.

Jon P. Stonehouse
BioCryst Pharmaceuticals, Inc. - CEO, President & Executive Director

Thank you, and thank you for that nice intro, Tazeen. It's been great to work with you over the years. Yes, a really exciting time in the company, and thank you for inviting us to your conference. I wish it was in Las Vegas, but we'll do it virtually yet another year.

And let me just quickly introduce the team that's with me. So our CFO, Anthony Doyle, is on; Chief Medical Officer, Bill Sheridan; Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot